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BEHAVIORAL NEUROSCIENCE
IntroductIon
Observations from the last decades have revealed an interplay 
between the immune and the central nervous systems in mood 
disorders like depression (Miller, 2010). On one hand, depressed 
patients frequently show alterations in their immune system and, on 
the other, inflammatory disorders or immunotherapies involving 
pro-inflammatory cytokines (mainly IL-2, TNF, and IFN-α), have 
been associated with depressive symptoms (Miller et al., 2009).
In parallel, in recent years, a considerable amount of evidence 
has showed that early life events can trigger programming effects 
in both the nervous and the immune systems. One of the best 
well-known programmers is the glucocorticoid dexamethasone, 
commonly administered to pregnant women at risk of premature 
delivery, and to premature neonates, in order to promote lung mat-
uration (Trautman et al., 1995; Hirvikoski et al., 2007; Karemaker 
et al., 2008; Hofmeyr, 2009; Mesquita et al., 2009). In fact, pre-
maturely born children neonatally treated with dexamethasone 
have, at school age, significantly lower plasma cortisol levels during 
and after exposure to a psychosocial stress test when compared to 
prematurely born non-treated children (Karemaker et al., 2008). 
This observation suggests that the activity of the hypothalamic–
pituitary–adrenal (HPA) axis is influenced by early treatment with 
dexamethasone. Of notice, this alteration is accompanied by an 
imbalanced cytokine profile. Specifically, production of IFN-γ upon 
stimulation of T cells with anti-CD2/CD28 monoclonal antibodies 
is significantly higher in children neonatally treated with dexam-
ethasone (Karemaker et al., 2008).
Several preclinical studies have also assessed the impact of prena-
tal glucocorticoid exposure. On the central nervous system side, it 
has been associated with disruption of the HPA axis and with altera-
tions on cognitive and motor development (Trautman et al., 1995; 
Welberg and Seckl, 2001; Coe and Lubach, 2005; Hirvikoski et al., 
2007; Mesquita et al., 2009). Furthermore it predisposes adult ani-
mals to anxiety and to depressive-like behavior after chronic mild 
stress in adulthood (Oliveira et al., 2006). However, the window 
of prenatal dexamethasone treatment seems to be crucial for the 
induction of long-lasting effects on the behavior in adulthood. In 
fact, dexamethasone treatment of rats, during the 3 weeks of gesta-
tion, does not induce alterations in the forced swim test (FST), while 
the same protocol administered only in the last week of gestation 
reduces the immobility time in the FST (Welberg and Seckl, 2001). 
Of interest, prenatal dexamethasone treatment leads to reduced 
volumes and cell number in the nucleus accumbens, which is a 
brain region strongly correlated with a reduced rate of cell prolifera-
tion (Leao et al., 2007) and is suggested to predispose to addictive 
behavior (Rodrigues et al., 2010). On the immune system side, early 
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 antibodies (Table 1) for 20 min on ice. Cell surface  markers were 
analyzed using specific antibodies for CD11 b/c (OX-42), CD45RA 
(OX-33; Caltag, CA, USA), CD161 (10/78), CD25 (OX-39), CD4 
(W3/25), CD8 (G28; BioLegend, San Diego, CA, USA), granulocytes 
(RP-1; BD Pharmingen, San Diego, CA, USA), Foxp3 (FJK-16a), 
CD3 (G4.18; eBioscience, San Diego, CA, USA). All cells were fixed 
with 2% formaldehyde after staining. A total of 50,000 events were 
acquired on a FACSCalibur flow cytometer (Becton Dickinson, NJ, 
USA) using the Cell Quest software (Becton Dickinson, NJ, USA); 
analysis of the cell populations was performed using the FlowJo 
software (Tree Star, Ashland, OR, USA).
MultIplex cytokIne AnAlysIs
The concentration of a panel of cytokines (IL-1β, IL-6, IFN-γ, IL-4, 
IL-10) was measured both in serum and in spleen cells supernatants 
stimulated in vitro with lipopolysaccharide (LPS, a component of 
the cell wall of Gram-negative bacteria) or with no stimulus, using 
a rat Bio-Plex cytokine assay (Bio-Rad, Hercules, CA, USA). The 
rat Bio-Plex cytokine assay was performed according to the manu-
facturer instructions. The sensitivity ranges were of 11.80 pg/mL 
for IL-1β, 0.11 pg/mL for IL-4, 0.93 pg/mL for IL-6, 3.44 pg/mL 
for IL-10, and 0.30 pg/mL for IFN-γ.
In vItro stIMulAtIon of spleen cells
Spleen cells (prepared as described previously), resuspended in 
DMEM (supplemented with 10% heat inactivated FCS, 10 mM 
HEPES buffer, 1 mM sodium pyruvate, 2 mM l-glutamine, 50 μg/
mL streptomycin, and 50 U/mL penicillin, all from Invitrogen, CA, 
USA), were distributed into 96-well plates (5 × 105 cells/well), in trip-
licate wells, and incubated with or without 5 μg/ml LPS (Escherichia 
coli, serotype O26:B6; Sigma, St Louis, USA). Supernatants were 
collected after 48 h incubation at 37°C, 5% CO
2
 atmosphere, and 
frozen at −80°C until use.
rAt InfectIon And quAntIfIcAtIon of orgAn bActerIAl loAds
At 3 months of age rats were intravenously infected through a 
lateral tail vein with 106 colony-forming units (CFU) of Listeria 
monocytogenes EGDe (provided by Dr. S. Sousa and Dr. D. Cabanes, 
Instituto de Biologia Molecular e Celular, Porto, Portugal). We 
performed preliminary experiments and confirmed that the well-
established  protocol of L. monocytogenes infection (Goettsch et al., 
life treatment with dexamethasone in animal models consistently 
suggests a long-term impact on the immune function, namely in 
the structure of the thymus (Dietert et al., 2003), T cell proliferation 
(Coe and Lubach, 2000), cytokine production (Bakker et al., 2000; 
Dietert et al., 2003), and in the predisposition to autoimmune dis-
orders (Bakker et al., 2000), even though the results are not always 
concordant. Curiously, although several studies demonstrate that 
prenatal administration of dexamethasone impacts on the immune 
and central nervous systems, the specific effects are quite discordant 
between studies, probably due to differences in the administration 
period (during pregnancy or soon after birth) or dosage, and also 
in the age in which the animals are analyzed.
Given the World Health Organization’s advice that corticoster-
oid therapy should be incorporated into comprehensive maternal 
health-care services, and included in official guidelines for mater-
nity care (Hofmeyr, 2009), it is crucial to understand its potential 
long-term impact in the immune and central nervous systems and 
on their interplay. A better perspective of the full spectrum of effects 
triggered by glucocorticoid therapy during pregnancy requires a 
combined multimodal approach, in the same animal model, that 
assesses the impact in the immune system and in behavioral altera-
tions, which is the focus of the present study.
MAterIAls And Methods
AnIMAls And dexAMethAsone AdMInIstrAtIon
Female Wistar rats with 14 days of pregnancy were purchased 
from Charles River Laboratories (Barcelona, Spain) and individu-
ally housed. Subcutaneous injections of dexamethasone (1 mg/
kg) or saline were administered on pregnancy days 18 and 19 
(Oliveira et al., 2006, 2010; Leao et al., 2007). For each experi-
ment 12 pregnant dams were used (6 for dexamethasone treatment 
and 6 controls with saline). The male progeny was separated on 
postnatal day 21 and housed according to the prenatal treatment 
(Dexa or Sal) in groups of two to three animals per cage from the 
same litter. Each group (Sal or Dexa) was constituted with animals 
from distinct litters (no more than three animals from each litter 
per experimental group). All animals were housed in an animal 
facility at 22°C, relative humidity of 55%, in a 12 h light/12 h 
dark cycle, with food and sterile tap water available ad libitum. 
The experimental procedures were performed at 3 months of age. 
The biometric parameter assessed were body spleen, thymus, and 
adrenal glands weights (at sacrifice). Blood from sacrificed rats 
was allowed to clot and the serum, collected after centrifugation, 
was frozen at −80°C until use. All animal experiments were per-
formed in accordance with National and European Commission 
guidelines for the care and handling of laboratory animals and 
were approved by the National Veterinary Directorate and by the 
local Animal Ethical Committee.
flow cytoMetry
To evaluate the proportion of the distinct populations of the 
immune system, flow cytometry was performed using single-cell 
suspensions from spleen and thymus. Splenic erythrocytes were 
depleted by incubation with a hemolytic solution (155 mM NH
4
Cl, 
10 mM KHCO
3
, pH 7.2) for 5 min at room temperature. For cell 
surface staining, 5 × 105 cells were used (in the case of Foxp3  staining, 
106 cells) from each individual rat and incubated with specific 
Table 1 | Antibodies used for identification of different spleen cells.
Immune cells Phenotype
CD4+ T cells CD3+ CD4+ (gated lymphocytes in FSC, SSC)
CD8+ T cells CD3+ CD8+ (gated lymphocytes in FSC, SSC)
CD4+ regulatory T cells  CD3+ CD4+ CD25+ Foxp3+ (gated lymphocytes
 in FSC, SSC)
NKT cells CD3+ CD161+
B cells CD45Ra+ (gated lymphocytes in FSC, SSC)
Macrophages CD11bc+ (gated in all cells except granulocytes
 in FSC, SSC)
Neutrophils CD11bc+ granulocytes+ (gated granulocytes in
 FSC, SSC)
NK cells CD3− CD161high+
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prenatally treated with dexamethasone showed an increased immo-
bility time (t = 2.4, P = 0.02) as well as a trend for decreased latency 
to immobility time in the FST (Figure 2A). Accordingly, a reduced 
hedonic behavior was also observed in the Dexa animals since they 
presented a decrease in the sucrose preference (Figure 2B) when 
compared with Sal rats (t = 2.9, P = 0.0065).
As our protocol of dexamethasone prenatal administration 
causes a disruption on the HPA axis (Oliveira et al., 2006), we deter-
mined biometric parameters known to be influenced by altered 
corticosteroid levels. Even though changes in body, spleen, and 
adrenal glands weight were not observed, we found a decreased thy-
mus weight (t = 2.4, P = 0.02) in Dexa rats (Figure 1). The thymus, 
in particular the CD4+ CD8+ thymocyte population, is extremely 
sensitive to corticosteroids (Ashwell et al., 2000). Therefore, we 
evaluated the impact of prenatal dexamethasone administra-
tion on the four main thymic cell populations: double negative 
(CD4− CD8−), double positive (CD4+ CD8+), CD4 single positive 
(CD3+ CD4+ CD8−), and CD8 single positive (CD3+ CD4− CD8+). 
Interestingly, despite the decrease in thymus weight, no alterations 
were observed in the proportions of the four main thymic cell 
populations (Figure 3A).
1996; Cabanes et al., 2008) is replicated in rats. At days 2, 4, and 8 
post infection rats were sacrificed and spleen and liver were asep-
tically collected for bacterial load evaluation. Briefly, organs were 
homogenized, serially diluted in ice-cold water and plated onto 
Brain Heart Infusion medium (BHI; Laboratorios Conda, Spain). 
The plates were incubated for 1 day at 37°C and the number of 
CFU counted.
forced swIMMIng test
Learned helplessness was evaluated in the FST. This protocol was 
performed in non-infected animals and 4 days after infection with 
L. monocytogenes, as previously described (Goncalves et al., 2008). 
Briefly, a pre-test session was performed by placing the rats for 
5 min in cylinders filled with water (24 ± 1°C), depth enough so 
they could not support themselves by placing the paws or tail on 
the base of the cylinders. After 24 h animals were tested during 
5 min. Only the second session was recorded and later scored by 
two independent researchers who were blind to the experimental 
conditions. Immobility time and latency to immobility were com-
puted and used as a measure of depressive-like behavior.
sucrose preference test
Anhedonic behavior was assessed by the sucrose preference test 
(SPT) as described previously (Bessa et al., 2009). Briefly, all animals 
were food and water deprived for 24 h and exposed afterward to two 
bottles either with 1% of sucrose solution or with sterile tap water 
for a period of 1 h. To avoid possible effects of side preference in 
drinking behavior, the position of the bottles was switched in each 
trial and the test was performed three times in a period of 2 weeks. 
Sucrose preference was calculated as the percentage of consumed 
sucrose solution of the total of liquid drunk.
stAtIstIcAl AnAlysIs
All data are represented as mean + SEM. Data were verified for 
Gaussian distribution. Student’s t test was used to calculate dif-
ferences between the Sal and Dexa groups. For the analysis of 
cytokine production upon LPS stimulation, statistical analysis 
was performed with the non-parametric Mann–Whitney U test. 
The impact of L. monocytogenes on cell types, cytokines levels and 
CFU after 2, 4, and 8 days of infection were analyzed with two-way 
ANOVA. Significance is referred as * for P < 0.05.
results
prenAtAl dexAMethAsone treAtMent Induces depressIve-lIke 
behAvIor And AlterAtIons In the Adult IMMune systeM
Prenatal dexamethasone treatment did not impact on litter size 
nor on the sex of the progeny since pregnant rats injected with 
saline (Sal) or dexamethasone (Dexa) had an average of 10 rats 
per litter with a 50% average of male and female. The progeny of 
dexamethasone-treated dams presented, as expected, reduced body 
weight at birth, which remained significantly reduced at 60 days of 
age (Oliveira et al., 2006), but no longer at 3 months when body 
weight was identical in both treatment groups (Figure 1).
To investigate the impact of prenatal administration of dexam-
ethasone on behavior and on the immune system we first analyzed 
the depressive-like behavior of rats in the FST and SPT, at 3 months 
of age. When compared to prenatally vehicle-injected rats, animals 
FIgure 1 | Prenatal treatment with dexamethasone induces decreased 
thymic weight in adulthood. Body, spleen, thymus, and adrenal glands 
weight were measured at 3 months of age in rats prenatally treated either 
with saline or with dexamethasone. Each bar represents the mean + SEM, 
from eight to nine rats per group from one of four independent experiments.
A B
FIgure 2 | Prenatal administration of dexamethasone induces 
depressive-like behavior. (A) Latency to first immobility and duration of 
immobility in the forced swim test and (B) sucrose preference were assessed 
in Sal and Dexa rats. Each bar represents the mean + SEM from 16 to 17 rats 
per group. Data from SPT are representative from three independent trials.
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IL-6 when compared with cells from the Sal group (U = 51, P = 0.002; 
Figure 5), thus showing an exacerbated pro-inflammatory response 
to this inflammatory stimulus. No differences were observed in the 
production of IL-1β, IFN-γ, IL-4, or IL-10 (Figure 5).
In addition, we studied the impact of an in vivo acute infection 
in the immune response and behavior. We chose to test the immune 
response to the acute L. monocytogenes intracellular infection, as this 
response is mainly mediated by CD8+ T cells (Pamer, 2004), which we 
found to be decreased in Dexa rats. Interestingly, at 2, 4, and 8 days 
post infection no differences were observed in body, spleen, thymus, 
or adrenal glands weight (data not shown). Moreover, the altera-
tions in non-infected Dexa rats spleen cell populations (Figure 3B) 
disappeared upon infection with L. monocytogenes (Figure 6). In 
fact, during the course of infection (2, 4, and 8 days), no major dif-
ferences were observed in total CD4+, CD8+, CD4+ regulatory and 
NK T cells, B cells, macrophages, neutrophils or NK cells between 
Sal and Dexa rats (Figure 6). However, two-way ANOVA showed 
a significant effect of time in the percentage of CD8+ (F
2,36
 = 35.8, 
P < 0.0001), CD4+ regulatory (F
2,36
 = 11, P = 0.0002), NK (F
2,37
 = 74.7, 
P < 0.0001) T cells, macrophages (F
2,37
 = 7.6, P = 0.002), neutrophils 
(F
2,36
 = 13.9, P < 0.0001), and NK cells (F
2,36
 = 36.1, P < 0.0001). 
Time of infection also impacted on the levels of IL-6 (F
3,38
 = 3.06, 
P = 0.0398), IL-10 (F
3,38
 = 12.38, P < 0.0001).
No differences between Sal and Dexa groups were found in the 
serum levels of IL-1β, IL-6, IFN-γ, IL-4, and IL-10 at any time point 
of infection (2, 4, and 8 days; Figure 7). In accordance, the evalua-
tion of the bacterial load revealed identical susceptibility to acute 
infection with L. monocytogenes (Figure 8). Altogether these results 
showed that Dexa rats can mount an appropriate immune response 
to this particular infection.
In parallel, we assessed depressive-like behavior at 4 days upon 
infection. In the FST, as previously observed (Figure 2), non-
infected Dexa rats presented a decreased latency time (t = 2.9, 
P = 0.01) and increased immobility time (t = 2.3, P = 0.03) when 
compared to Sal (Figure 9). Curiously, 4 days after infection these 
differences disappeared (Figure 9), as infection triggered, in Sal rats, 
an increase in immobility time almost statistical significant (t = 2.1, 
P = 0.06) when compared to Sal non-infected rats (Figure 9).
To further explore the immune system, we subsequently studied 
the immune cell populations present in the spleen of Dexa and Sal 
rats. Prenatal treatment with dexamethasone induced, in adult-
hood, a decrease in CD8+ T cells (t = 2.9, P = 0.01) and an increase 
in both B (t = 4.7, P = 0.0004) and CD4+ regulatory T cells (t = 3, 
P = 0.006) in the spleen (Figure 3B). No differences were observed 
in the percentage of total CD4+ and NK T cells, macrophages, neu-
trophils or in NK cells of Dexa rats when compared to Sal animals 
(Figure 3B). Interestingly, we searched for correlations between 
the behavior in the FST and SPT and the percentage of immune 
cells in the spleen and only a negative correlation between latency 
time of the FST and the percentage of CD8+ T cells (r = −0.8089, 
P = 0.0003) was observed. Moreover an almost significant negative 
correlation between the percentage of B cells and latency time in 
FST (r = 0.4893, P = 0.0542) was also present.
Finally, we measured the levels of cytokines, which are key play-
ers in the communication between the immune and the central 
nervous systems known to be involved in the pathology of mood 
disorders (Miller et al., 2009). In basal conditions, Dexa rats pre-
sented an overall reduction in the serum levels of the cytokines 
analyzed (IL-1β, IL-6, IFN-γ, IL-4, IL-10) when compared with Sal 
(Figure 4); however, only the reductions in IL-6 (t = 2.7, P = 0.01) 
and IL-10 (t = 2.3, P = 0.03; a pro- and an anti-inflammatory 
cytokine, respectively) reached statistical significance (Figure 4).
dexA rAts show An IncreAsed pro-InflAMMAtory profIle After 
In vItro lps stIMulAtIon but no dIfferences In depressIve-lIke 
behAvIor or In the IMMune response to LIsterIa 
monocytogenes InfectIon
Since we found that prenatal dexamethasone treatment induces, in 
adulthood, alterations in spleen immune cell populations and in the 
serum cytokine profile, we next asked how the immune system react 
to external stimuli and how would this impact on depressive-like 
behavior. For that, since Dexa rats present an increase in the percent-
age of B cells and LPS is a B cell mitogen (Sultzer and Goodman, 
1976), we first stimulated splenocytes with LPS and analyzed the 
production of a panel of cytokines. Upon in vitro stimulation with 
LPS, spleen cells from Dexa rats displayed increased production of 
A B
FIgure 3 | Prenatal dexamethasone treatment induces, in the adult 
progeny, alterations in splenic CD8+ and CD4+ regulatory T and on B cells 
but not in the proportion of the four main thymic cell populations. (A) 
Thymocytes from Sal and Dexa groups were stained with specific antibodies 
and analyzed by flow cytometry. Data are represented as the mean + SEM, 
from eight rats per group from one of four independent experiments.  
(B) Splenocytes from Sal and Dexa groups were stained with specific 
antibodies and analyzed by flow cytometry. Each bar represents the  
mean + SEM from 9 to 12 animals per group from one of three 
independent experiments.
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was also observed by others, after dexamethasone prenatal treat-
ment (Hauser et al., 2009). The fact that Oliveira et al. (2006) did 
not observe altered behavior in the FST is likely related with the 
age of the animals, studied at 8 months; as has also been shown 
in the case of anxious-like behavior (present at 2 months and no 
longer at 8 months of age).
In the present study we extend the link of depressive-like phe-
notype observed in this animal model (increased immobility in 
the FST and decreased sucrose preference) to alterations in the 
immune system that may be linked to HPA dysregulation. In fact, 
HPA axis alterations are described to impact in the immune system 
homeostasis. As an illustration, the high sensitivity of the thymus 
to corticosteroids, given the expression of glucocorticoid receptors 
in thymic cells throughout life, is well-established (Ashwell et al., 
2000). We now confirmed a sustained decrease in the thymus weight 
of adult rats treated prenatally with dexamethasone, even though no 
alterations were observed in the basal levels of corticosterone (data 
not shown). Others have shown that dexamethasone administration 
during the two last thirds of gestation leads to a marked alteration in 
the thymus structure in juvenile (5 weeks of age) and in adults rats 
dIscussIon
The present study combined a behavioral and an immunological 
assessment of rats prenatally exposed to dexamethasone. The data 
collected show that these animals, when adults, display a depressive-
like phenotype that is associated with decreases in IL-6 and IL-10 
serum levels and with alterations in spleen immune cell populations 
(decrease in the percentage of CD8+ T cells and increase in regula-
tory CD4+ T and B cells). Moreover, spleen cells of Dexa rats display, 
after stimulation with LPS, an increased pro-inflammatory profile 
of cytokine production. However, rats treated with dexamethasone 
during the prenatal period do not show alterations in the suscep-
tibility to acute infection with L. monocytogenes. Interestingly, this 
infection does not aggravate the depressive-like phenotype already 
present in non-infected Dexa animals.
The rat model used in this study has previously been shown to 
have disruption on the HPA axis (Oliveira et al., 2006). Thus, it is 
not surprising that prenatal dexamethasone treatment was able to 
induce depressive-like behavior (decrease latency time and increase 
immobility time in the FST and decreased sucrose preference) in 
3 months old rats. Accordingly, increased immobility in the FST 
FIgure 4 | Prenatal treatment with dexamethasone induces a decrease in adult serum IL-6 and IL-10 levels. Serum IL-1β, IL-6, IFN-γ, IL-4, and IL-10 
concentrations were determined using a multiplex cytokine assay. Each point represents one rat and the line corresponds to the mean of 12–13 rats per group from 
two independent experiments. DL, detection limit.
FIgure 5 | Splenocytes from Dexa rats produce increased levels of IL-6 after LPS stimulation. Spleen cells from Sal and Dexa rats were stimulated with LPS 
(5 μg/mL) during 48 h. Cytokine concentrations were determined by a multiplex cytokine assay in culture supernatants. Each point represents one rat and the line 
corresponds to the mean of 12–13 rats per group from two independent experiments.
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In line with the above mentioned hypothesis, we show herein, 
for the first time, alterations in the homeostasis of the spleen 
cells in adult animals prenatally treated with glucocorticoids. In 
fact, we found a decrease in the percentage of CD8+ T cells in 
the spleen of Dexa animals; yet, we cannot at this point ascribe 
these changes to thymic T cell differentiation, namely because 
there were no changes in the proportion of major thymic cell 
populations. Additionally, prenatal dexamethasone treatment also 
increased the percentage of CD4+ regulatory T cells (CD4+ CD25+ 
Foxp3+). Interestingly, previous studies have shown that in vitro 
incubation of human CD4+ T cells with dexamethasone leads to 
upregulation of the mRNA levels of Foxp3 (Karagiannidis et al., 
2004). This suggests an interaction between corticosteroids and 
(13 weeks of age; Dietert et al., 2003). Interestingly, in adulthood, 
we found that the proportion of all major thymic cell populations 
was unaffected, which fits previous observation in a similar model 
(prenatal treatment of dexamethasone 400 μg, intraperitoneally, 
on days 17 and 19 of gestation; Bakker et al., 1995). However, it 
should be noticed that this adulthood stability was preceded by 
significant alterations in the proportion of thymocyte populations 
(Bakker et al., 1995). More importantly, there is evidence that corti-
costeroids are involved in thymocyte selection, as neonatal treatment 
with dexamethasone was reported to induce alteration in the T cell 
receptor Vβ repertoire (Bakker et al., 2001); this may cause long-
lasting alterations in the T cell repertoire and in the susceptibility 
to T cell related-disorders.
FIgure 7 | Adult rats prenatally treated with Dexa or with Sal present a similar serum cytokine profile after L. monocytogenes. IL-1β, IL-6, IFN-γ, IL-4, and 
IL-10 production upon infection was determined measuring their serum concentration with a multiplex cytokine assay. Each point represents one rat and the line 
corresponds to the mean of six to eight rats per group.
FIgure 6 | Infection with L. monocytogenes results in a similar percentage of spleen cell populations in Sal and Dexa rats. Two, four, and eight days after 
L. monocytogenes infection, spleen cells from Sal and Dexa groups were stained with specific antibodies and analyzed by flow cytometry. Each bar represents the 
mean + SEM from six to eight animals per group.
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The most likely mediators of the cross-talk between the immune 
and the nervous systems are cytokines. Several studies have demon-
strated their role in the pathophysiology of depression (Miller et al., 
2009). Since we showed that prenatal dexamethasone administra-
tion can induce alterations in adults’ immune cells we also analyzed 
the production of cytokines. In basal conditions, a tendency for an 
overall decrease in the production of all cytokines analyzed in the 
serum was observed, but only IL-6 and IL-10 levels were significantly 
reduced. It is important to note that the anti-inflammatory cytokine 
IL-10 has been shown to play a major role in depression. In fact, the 
absence of IL-10 is able to induce, in mice, depressive-like behavior 
and IL-10 administration rescues this phenotype (Mesquita et al., 
2008). Moreover, due to the interplay between IL-10 and glucocor-
ticoids, it has been suggested that this anti-inflammatory cytokine 
can be a putative link between disruption of the HPA axis and the 
imbalanced production of cytokines observed in depressed patients 
(Roque et al., 2009). Accordingly, in this distinct rat model, we found: 
(i) disruption of the HPA axis (Oliveira et al., 2006); (ii) decreased 
levels of IL-10; and (iii) depressive-like behavior.
Assessment of basal conditions in regulatory systems, such as the 
nervous and the immune systems, can only provide a “one-side of 
the coin perspective”. In fact, the ability of these regulatory systems to 
tackle with challenges is critical for their evaluation. Our present data 
certainly confirms this perspective. After a challenge with LPS, spleen 
cells from rats prenatally treated with dexamethasone respond with 
an increased production of IL-6. Taking into account that LPS is 
recognized by Toll-like receptor 4 (TLR4), this result shows that there 
is an over reactive innate response to this stimulus. Of notice, there 
is evidence that dexamethasone can increase the expression of TLR4 
(Galon et al., 2002). Thus, pre-exposure to dexamethasone has been 
shown to enhance LPS responsiveness (Barber et al., 1993; Zhang 
and Daynes, 2007). Irrespectively from the underlying mechanism, 
the present data show an increased pro-inflammatory profile in 
response to LPS in animals prenatally treated with dexamethasone, 
which fit previous observations by Bakker et al. (2000) in rodents, 
but also a human study that revealed that premature newborns 
treated with dexamethasone present, at school age, a shift toward a 
more pro-inflammatory cytokine profile (Karemaker et al., 2008).
Our next step was to perform a multimodal analysis after a com-
bined innate/acquired immune stimulus through infection with 
L. monocytogenes. CD8+ T cells, which we found decreased in pre-
natally treated Dexa rats, play a major role in the immune response 
to L. monocytogenes. After acute infection, the differences observed 
in the proportion of spleen CD8+ T cells between non-infected Dexa 
and Sal animals disappeared. Moreover, the proportion of all spleen 
cell populations became identical between dexamethasone- and 
vehicle-exposed rats. This suggests that despite an altered homeos-
tasis of the immune system, Dexa animals can mount an adequate 
immune response to L. monocytogenes infection. In accordance, no 
changes were found in the serum cytokine profile. It is therefore 
not surprising that the bacterial load in both groups of animals was 
also similar. Altogether, prenatal dexamethasone treatment does not 
cause alterations in susceptibility to acute infection with this Gram-
positive bacterium. Of relevance, we observed that L. monocytogenes 
infection in Sal animals triggered a trend for depressive-like behavior 
(P = 0.06), which fits the hypothesis that the increased production 
of pro-inflammatory cytokines is linked to alterations in emotional 
the formation of regulatory T cells. However, this is the first study 
showing that prenatal dexamethasone treatment can induce, in 
adulthood, alterations in the proportion of CD4+ regulatory T 
cells, a subtype of cells of crucial relevance not only in the immune 
system response, but also in the modulation of depressive-like 
behavior (Rook and Lowry, 2008; Miller, 2010). A final note to 
the fact that B cells were also increased in the spleen of adult rats 
prenatally treated with dexamethasone. Since, in rodents, B cells 
immunoglobulins expression appears in the liver, spleen, and bone 
marrow at day 17 of gestation (Holladay and Smialowicz, 2000), 
it seems reasonable to suggest that dexamethasone administra-
tion on days 18 and 19 of gestation also targeted the function of 
B cells. Interestingly, we observed a negative correlation between 
the percentage of CD8+ T cells and the latency time in the FST, and 
an almost positive correlation between the percentage of B cells 
and the same behavioral parameter. These correlations suggest 
that alterations in depressive-like behavior may be associated with 
differences in the percentage of specific immune cells populations, 
which should next be further investigated.
FIgure 8 | No differences in susceptibility to L. monocytogenes infection 
were observed between Sal and Dexa rats. The bacterial loads of Sal and 
Dexa rats infected with L. monocytogenes were determined at 2, 4, and 
8 days post infection in spleen and liver. Data are represented as the 
mean + SEM from seven to nine rats per group.
FIgure 9 | Infection with L. monocytogenes does not aggravate the 
depressive-like behavior of Dexa animals. Latency to first immobility and 
duration of immobility in the forced swim test were assessed in Sal and Dexa 
rats non-infected and 4 days after infection with L. monocytogenes (4 dpi). 
Each bar represents the mean + SEM from seven to nine rats per group.
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behavior. As Dexa rats already presented depressive-like phenotype 
in basal conditions, we did not observe a significant aggravation of 
this behavior phenotype.
In conclusion, we herein show that prenatal administration of 
dexamethasone induces, in adulthood, depressive-like behavior and 
immune system alterations. Additional studies should next address 
which are the precise mediators of such interplay.
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